Skip to main content

Peer Review reports

From: Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)

Original Submission
17 Feb 2022 Submitted Original manuscript
23 Mar 2022 Reviewed Reviewer Report
6 Apr 2022 Reviewed Reviewer Report
9 May 2022 Author responded Author comments - Sha Zhu
Resubmission - Version 2
9 May 2022 Submitted Manuscript version 2
14 May 2022 Reviewed Reviewer Report
27 May 2022 Reviewed Reviewer Report
31 May 2022 Author responded Author comments - Sha Zhu
Resubmission - Version 3
31 May 2022 Submitted Manuscript version 3
Publishing
7 Jun 2022 Editorially accepted
22 Jul 2022 Article published 10.1186/s12916-022-02430-0

You can find further information about peer review here.

Back to article page